Pivmecillinam

Selexid 400 MG Comprimidos Recubiertos con Pelicula Efg

400 mg comprimido recubierto con películaSpainMarketedAuthorised 21 Jul 2017

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Pivmecillinam

Selexid 400 MG Comprimidos Recubiertos con Pelicula Efg

400 mg comprimido recubierto con películaSpainMarketedAuthorised 21 Jul 2017

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Packs

Pack	Code	Status
SELEXID 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 9 comprimidos	713845
SELEXID 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 10 comprimidos	730067

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Pivmecillinam
Strength: 400 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 21 Jul 2017
Registration: 81499
Marketing authorisation holder: Karo Pharma Ab
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica